IOB - Delayed Quote CHF
Sonova Holding AG (0QPY.IL)
275.50
-5.80
(-2.06%)
As of 9:19:45 AM GMT+1. Market Open.
Breakdown
TTM
3/31/2025
3/31/2024
3/31/2023
3/31/2022
Total Revenue
3,865,400
3,865,400
3,626,900
3,738,400
3,363,900
Cost of Revenue
1,080,900
1,080,900
1,016,500
1,101,000
903,300
Gross Profit
2,784,500
2,784,500
2,610,400
2,637,400
2,460,700
Operating Expense
2,092,600
2,092,600
1,940,500
1,890,600
1,700,600
Operating Income
691,900
691,900
669,900
746,800
760,100
Net Non Operating Interest Income Expense
-45,400
-45,400
-27,000
-34,800
-34,800
Pretax Income
652,000
652,000
647,300
715,600
728,200
Tax Provision
105,000
105,000
37,800
57,400
64,500
Net Income Common Stockholders
540,500
540,500
601,000
647,500
649,000
Diluted NI Available to Com Stockholders
540,500
540,500
601,000
647,500
649,000
Basic EPS
9.07
9.07
10.08
10.75
10.42
Diluted EPS
9.04
9.04
10.05
10.72
10.35
Basic Average Shares
59,599.34
59,599.34
59,630.11
60,224.26
62,270.28
Diluted Average Shares
59,783.41
59,783.41
59,790.81
60,433.13
62,711.01
Total Operating Income as Reported
691,900
691,900
669,900
746,700
760,000
Total Expenses
3,173,500
3,173,500
2,957,000
2,991,600
2,603,900
Net Income from Continuing & Discontinued Operation
540,500
540,500
601,000
647,500
649,000
Normalized Income
540,500
540,500
601,000
647,500
649,000
Interest Income
4,400
4,400
4,800
1,500
1,400
Interest Expense
26,500
26,500
28,200
23,400
21,600
Net Interest Income
-45,400
-45,400
-27,000
-34,800
-34,800
EBIT
678,500
678,500
675,500
739,000
749,800
EBITDA
927,000
927,000
921,700
978,700
960,900
Reconciled Cost of Revenue
1,080,900
1,080,900
1,016,500
1,101,000
903,300
Reconciled Depreciation
248,500
248,500
246,200
239,700
211,100
Net Income from Continuing Operation Net Minority Interest
540,500
540,500
601,000
647,500
649,000
Total Unusual Items Excluding Goodwill
-3,400
--
--
--
-12,900
Total Unusual Items
-3,400
--
--
--
-12,900
Normalized EBITDA
927,000
927,000
921,700
978,700
960,900
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
3/31/2022 - 3/7/2014
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
NEOLA.ST Neola Medical AB (publ)
2.5100
+2.87%
FA0.F PExA AB (publ)
0.0210
+13.51%
0K9P.IL GN Store Nord A/S
93.52
-1.16%
ONCSM.IS Oncosem Onkolojik Sistemler Sanayi Ve Ticaret Anonim Sirketi
90.55
-0.55%
2TG.BE Steris PLC
218.00
-0.91%
S1TE34.SA STERIS plc
64.61
0.00%
PHIA.BE Koninklijke Philips NV
21.00
-0.94%
WDH1.F Demant A/S
35.40
-0.06%
0Q15.IL Abbott Laboratories
136.29
+0.82%
SPEC.ST SpectraCure AB (publ)
0.7710
+0.92%